Unfortunately, no average difference in p16INK4a levels was detected between a group of various childhood cancer survivors who had received radiotherapy as part of their treatment and a group of healthy participants (n = 11, data not shown). The gene discussed is CDKN2A; the disease is childhood malignant neoplasm.